Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification

Mi Kyung Lee1, Yoonsuk Jekal, Jee-Aee Im

  • 1Department of Sport and Leisure Studies, Yonsei University, Seoul, Republic of Korea.

Insights

Visceral adipose tissue-derived serpin (vaspin) predicts insulin resistance in obese children. Intensive lifestyle changes significantly lowered vaspin levels and improved metabolic markers.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome Research
  • Adipokine Signaling Pathways

Background:

  • Visceral adipose tissue-derived serpin (vaspin) is an adipokine with potential insulin-sensitizing properties.
  • Factors influencing circulating vaspin levels and its role in pediatric obesity remain incompletely understood.

Purpose of the Study:

  • To investigate the association between adiposity, insulin resistance, lipid profiles, and inflammatory markers, including vaspin levels, in overweight/obese children.
  • To evaluate the impact of short-term intensive lifestyle modification on circulating vaspin levels in this population.

Main Methods:

  • Cross-sectional analysis of 50 overweight/obese children (aged 11-13 years) to assess correlations between adiposity, metabolic markers, and vaspin.
  • A seven-day intensive lifestyle intervention involving diet, physical activity, and behavioral modification.

Main Results:

  • Serum vaspin negatively correlated with fasting insulin and HOMA-IR, independent of body fat percentage.
  • Short-term lifestyle modification significantly reduced vaspin levels by 39.28% (p<0.001) and increased adiponectin by 11.2% (p<0.01).
  • The intervention also led to significant improvements in HOMA-IR and lipid profiles.

Conclusions:

  • Serum vaspin is a predictor of insulin resistance in overweight and obese children.
  • Intensive, short-term lifestyle modification effectively reduces vaspin levels and ameliorates insulin resistance and dyslipidemia.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...